Approval is what establishes that a compound's benefits and risks have been characterised well enough for use in people, and retatrutide hasn't reached that bar
However, a weak immune system can allow these antigens or fungi to rapidly grow inside our body and cause fungal infections
In effect, the body composition ratio improved, shifting toward a leaner phenotype overall
Meanwhile, given the individual differences in gut microbiota composition and metabolic characteristics of osteoporosis patients, the risk of immune rejection and infection associated with long-term transplantation, and the ethical issues and informed consent related to the protection of donorrecipient privacy (125), there may still be a long way to go before the use of FMT in the management of osteoporosis
Pharmaceutical companies are investing in new formulations, including oral and long-acting options, as the market awaits decisions on broader reimbursement for obesity treatment and strategies to improve access
Sale restricted to qualified researchers
